[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353470-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353470-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","sfrp2-drives-aerobic-glycolysis-and-tumor-progression-in-ovarian-cancer-by-transcriptional-upregulation-of-ptk2b","SFRP2 drives aerobic glycolysis and tumor progression in ovarian cancer by transcriptional upregulation of PTK2B","","Ovarian cancer is a highly lethal gynecologic malignancy in which metabolic reprogramming contributes to progression and therapeutic resistance. Secreted Frizzled-Related Protein 2 (SFRP2) has been linked to several cancers, but its ovarian cancer function and molecular mechanisms, especially those governing metabolic pathways, remain insufficiently defined. Bioinformatic, clinical validation, and mechanistic studies evaluate how SFRP2 controls transcriptional regulation and glycolytic metabolism through CEBPA and PTK2B.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/sfrp2-drives-aerobic-glycolysis-and-tumor-progression-in-ovarian-cancer-by-transcriptional-upregulation-of-ptk2b/353470/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/sfrp2-drives-aerobic-glycolysis-and-tumor-progression-in-ovarian-cancer-by-transcriptional-upregulation-of-ptk2b/353470.png","ImageObject",300,407,{"name":42,"@type":43},"pixelkiddo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does SFRP2 play in ovarian cancer according to the study?","Question",{"text":63,"@type":64},"SFRP2 is significantly overexpressed in ovarian cancer tissues and cell lines, and higher expression associates with advanced disease and poor survival. Functionally, SFRP2 knockdown suppresses proliferation, colony formation, and migration while promoting apoptosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the study connect SFRP2 to transcriptional control of PTK2B?",{"text":68,"@type":64},"Mechanistically, SFRP2 interacts with the transcription factor CEBPA, promotes CEBPA nuclear translocation, and increases CEBPA occupancy at the PTK2B promoter, leading to enhanced PTK2B transcriptional activation.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence shows that aerobic glycolysis is required for SFRP2’s tumor-promoting effects?",{"text":72,"@type":64},"The study shows that blocking glycolysis with 2-DG or knocking down PTK2B reverses the oncogenic effects of SFRP2 in both ovarian cancer cell models and xenograft mouse models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353470,1790194792,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","Sheng et al. Journal of Translational Medicine (2026) 24:1153  \n[https://doi.org/10.1186/s12967-026-08480-9](https://doi.org/10.1186/s12967-026-08480-9)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nSFRP2 drives aerobic glycolysis and tumor progression in ovarian cancer by transcriptional upregulation of PTK2B  \nJindong Sheng1,2*†, Yiwen Xing3†, Jing Luan1,2, Xiangyu Liu1,2, Hualin Song1,2, Lu Sun1,2, Min Yu1,2, Xin Fu 1,2, Huijuan Wu1,2, Ying Chen1,2, Wenxin Liu1,2* and Ke Wang1,2*  \nAbstract  \nBackground Ovarian cancer is a highly lethal gynecologic malignancy, with metabolic reprogramming being a key contributor to its progression and therapeutic resistance. Although Secreted Frizzled-Related Protein 2 (SFRP2) has been implicated in various cancers, its functional role and molecular mechanisms in ovarian cancer, particularly in regulating metabolic pathways, remain poorly defined.  \nMethods Bioinformatic analyses of GEO (GSE66957) and TCGA-OV datasets were performed to assess SFRP2 expression and its prognostic correlation. Immunohistochemistry (IHC) on a human ovarian cancer tissue microarray was used for clinical validation. SFRP2 was knocked down or overexpressed in ovarian cancer cell  \nlines (HEY and SK-OV-3) using lentiviral shRNA vectors. Functional assays (CCK-8, colony formation, apoptosis, migration) and metabolic assays (glucose consumption, lactate/ATP production, ECAR/OCR) were conducted. The mechanistic link between SFRP2, transcription factor CEBPA, and downstream target PTK2B was investigated using co-immunoprecipitation (Co-IP), nuclear-cytoplasmic fractionation, chromatin immunoprecipitation (ChIP), and dualluciferase reporter assays. Rescue experiments were performed both in vitro and in vivo (xenograft mouse models) . Results SFRP2 was significantly overexpressed in ovarian cancer tissues and cell lines, and high SFRP2 expression correlated with advanced disease and poor patient survival. SFRP2 knockdown suppressed cell proliferation, colony formation, and migration, while promoting apoptosis. Mechanistically, SFRP2 interacted with the transcription factor CEBPA, promoted its nuclear translocation, and enhanced its occupancy at the PTK2B promoter, thereby driving PTK2B transcriptional activation. This SFRP2/CEBPA/PTK2B axis further activates the AKT/mTOR signaling pathway, upregulating key glycolytic enzymes. Importantly, inhibiting glycolysis with 2-DG or knocking down PTK2B effectively reversed the oncogenic effects of SFRP2 both in vitro and in vivo.  \n†Jindong Sheng andYiwen Xing contributed equally to this work.  \n*Correspondence:  \nJindong Sheng [sjd1987@163.com](sjd1987@163.com)  \nWenxin Liu [tjmuch_liuwenxin@126.com](tjmuch_liuwenxin@126.com)[ ](tjmuch_liuwenxin@126.com)Ke Wang [kewang12@163.com](kewang12@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nSheng et al. Journal of Translational Medicine (2026) 24:1153 Page 2 of 18  \nConclusion Our findings identify a novel SFRP2/CEBPA/PTK2B signalin","cbCairqRYabOhqQV","https://ap.wps.com/l/cbCairqRYabOhqQV","pdf",16140661,18,"English","# Abstract\n# Background\n## Metabolic reprogramming and chemoresistance\n## Warburg effect in ovarian cancer\n# SFRP2 and Wnt signaling in cancer\n# Methods\n## Bioinformatic analyses\n## Experimental validation and functional assays\n## Mechanistic studies and rescue experiments\n# Results\n## SFRP2 expression and patient outcome associations\n## Effects of SFRP2 knockdown or overexpression\n## SFRP2/CEBPA/PTK2B axis and AKT/mTOR activation\n## Glycolysis inhibition reverses oncogenic effects\n# Conclusion","[{\"question\":\"What role does SFRP2 play in ovarian cancer according to the study?\",\"answer\":\"SFRP2 is significantly overexpressed in ovarian cancer tissues and cell lines, and higher expression associates with advanced disease and poor survival. Functionally, SFRP2 knockdown suppresses proliferation, colony formation, and migration while promoting apoptosis.\"},{\"question\":\"How does the study connect SFRP2 to transcriptional control of PTK2B?\",\"answer\":\"Mechanistically, SFRP2 interacts with the transcription factor CEBPA, promotes CEBPA nuclear translocation, and increases CEBPA occupancy at the PTK2B promoter, leading to enhanced PTK2B transcriptional activation.\"},{\"question\":\"What evidence shows that aerobic glycolysis is required for SFRP2’s tumor-promoting effects?\",\"answer\":\"The study shows that blocking glycolysis with 2-DG or knocking down PTK2B reverses the oncogenic effects of SFRP2 in both ovarian cancer cell models and xenograft mouse models.\"}]","SFRP2 drives aerobic glycolysis and tumor progression in ovarian cancer by transcriptional upregulation of PTK2B | PDF",1790105615,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b814abeb5239cb7dd1fd05ef62959f2b.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10e5ce3af94b7536041b60326a4dcbd1.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3b44d0444c009937163ab36bfd1a20c.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6374363582ed8e774da6c4a491953121.webp",980,1306]